Evidence check: WeightLoss Slim DNA in the context of Wechseljahre

The term 'WeightLoss Slim DNA' is not a scientifically established concept but a marketing label for commercial genetic tests claiming personalized weight loss. In the context of menopause (Wechseljahre), the evidence for such tests is very weak. Weight gain during menopause is primarily driven by hormonal changes (declining estrogen), metabolic shifts, and lifestyle factors – not by single gene variants. While genes like FTO or APOC3 are associated with lipid metabolism, their effects are small (e.g., ~0.4 kg/m² per risk allele for FTO) and not specific to menopause. Most 'Slim DNA' tests rely on mechanistic or GWAS data that do not provide clinically relevant predictions for individual weight loss. Moreover, no robust studies demonstrate a benefit of such tests during menopause. A balanced diet, exercise, and possibly medical guidance (e.g., hormone therapy) remain far more effective. Conclusion: The evidence is largely marketing-driven; consumers should critically question high expectations from such tests.